Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. YungShin Global Holding Co's selling, general, & admin. expense for the
three
months ended in Mar. 2026 was NT$423 Mil.
Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2026 was NT$1,889 Mil.
YungShin Global Holding Co (TPE:3705) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
YungShin Global Holding Co Selling, General, & Admin. Expense Related Terms
YungShin Global Holding Co Selling, General, & Admin. Expense Historical Data
* Premium members only.
The historical data trend for YungShin Global Holding Co's Selling, General, & Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YungShin Global Holding Co Selling, General, & Admin. Expense Chart
TPE:3705 vs ZTS: Selling, General, & Admin. Expense Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, YungShin Global Holding Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YungShin Global Holding Co Selling, General, & Admin. Expense vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, YungShin Global Holding Co's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where YungShin Global Holding Co's Selling, General, & Admin. Expense falls into.
YungShin Global Holding Co Selling, General, & Admin. Expense Calculation
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,889 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Selling, General, & Admin. Expense of NT$1,889 Mil mean?
YungShin Global Holding Co (TPE:3705) has a Selling, General, & Admin. Expense of NT$1,889 Mil as of Mar. 2026. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on YungShin Global Holding Co and its competitors.
Is YungShin Global Holding Co's Selling, General, & Admin. Expense too high?
YungShin Global Holding Co's current Selling, General, & Admin. Expense is NT$1,889 Mil. Overall, YungShin Global Holding Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does YungShin Global Holding Co's Selling, General, & Admin. Expense compare to ZTS?
YungShin Global Holding Co's Selling, General, & Admin. Expense of NT$1,889 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Drug Manufacturers company?
A good Selling, General, & Admin. Expense depends on the Drug Manufacturers industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on YungShin Global Holding Co and its competitors. YungShin Global Holding Co's current Selling, General, & Admin. Expense is NT$1,889 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YungShin Global Holding Co stock overvalued right now?
Based on GuruFocus' analysis, YungShin Global Holding Co (TPE:3705) is currently considered Fairly Valued. The stock's GF Value™ is NT$55.47, compared to a current price of NT$53.70 — trading 3.2% below its estimated fair value. The current Selling, General, & Admin. Expense is NT$1,889 Mil. YungShin Global Holding Co's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For YungShin Global Holding Co (TPE:3705), the current Selling, General, & Admin. Expense is NT$1,889 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is YungShin Global Holding Co (TPE:3705) Overvalued in 2026?
Based on GuruFocus' analysis, YungShin Global Holding Co stock appears to be undervalued.
The current stock price of NT$53.70 is trading 3.2% below its estimated GF Value™ of NT$55.47.
GuruFocus considers YungShin Global Holding Co to be Fairly Valued.
Key valuation signals for TPE:3705:
Selling, General, & Admin. Expense: NT$1,889 Mil
GF Value™: NT$55.47 vs. price of NT$53.70 (3.2% below fair value)
No single metric tells the full story. See the TPE:3705 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
YungShin Global Holding Co Ltd invests, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics. The company derives revenue from the sale of Human drugs, Health food, Animal drugs, and Others. The company generates the majority of its revenue from Human drugs. Geographically, the company generates the revenue from Taiwan, the USA, Japan, and China, out of which the majority of its revenue is generated from Taiwan.
88GF Score
Get the complete analysis for TPE:3705
Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:3705 has been successfully added to your 
